Results 31 to 40 of about 135,991 (315)

Investigation of Cost and Medical Service Fee for Pharmaceutical Management in Home Medical Care

YAKUGAKU ZASSHI, 2004
Due to the evolvement of the aged society and the steep rise in medical costs, the environment encircling the medical care industry has been changing remarkably. For this reason, it has become both necessary and fundamental for a community pharmacist to participate in home medical care through the pharmaceutical management service.
Katsuaki, Honma, Ritsuko, Sakai, Akiko, Takeshima, Yoshimitsu, Shimamori, Yukitoshi, Hayase   +4 more
openaire   +3 more sources

Evaluating the effect of a proposed logistics fee cap on pharmaceuticals in South Africa - a pre and post analysis [PDF]

BMC Health Services Research, 2015
South Africa has proposed the implementation of a maximum logistics fee paid by pharmaceutical manufacturers to wholesalers and distributors. However very little knowledge exists of the effects, unintended or otherwise, of the implementation of these proposed regulations, which are required to guide further policy development and implementation.
Bangalee, Varsha, Suleman, Fatima
openaire   +2 more sources

Second-Generation Dispute System Design Issues in Managing Settlements [PDF]

, 2008
Published in cooperation with the American Bar Association Section of Dispute ...
McGovern, Francis
core   +1 more source

Establishment of a humanized patient‐derived xenograft mouse model of high‐grade serous ovarian cancer for preclinical evaluation of combination immunotherapy

Molecular Oncology, EarlyView.
We have established a humanized orthotopic patient‐derived xenograft (Hu‐oPDX) mouse model of high‐grade serous ovarian cancer (HGSOC) that recapitulates human tumor–immune interactions. Using combined anti‐PD‐L1/anti‐CD73 immunotherapy, we demonstrate the model's improved biological relevance and enhanced translational value for preclinical ...
Luka Tandaric, Line Bjørge, Martine Rott Lode, Cecilie Fredvik Torkildsen, Pia Aehnlich, Rammah Elnour, Daniela Elena Costea, Lars Andreas Akslen, Liv Cecilie Vestrheim Thomsen, Emmet McCormack, Katrin Kleinmanns   +10 more
wiley   +1 more source

Conflicts of Interest Among Cardiology Clinical Practice Guideline Authors in Japan

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Clinical practice guidelines (CPGs) offer disease management recommendations based on scientific evidence. However, financial conflicts of interest between CPG developers and the pharmaceutical industry could bias these recommendations ...
Anju Murayama, Megumi Aizawa, Keerthana R. Byreddy, Kenichi Higuchi, Yuki Senoo   +4 more
doaj   +1 more source

Multi stakeholders of health and industries perspectives on medicine price transparency initiative in private health care settings in Malaysia

Saudi Pharmaceutical Journal, 2020
Introduction: Medicine price transparency initiatives provide public or government on information about the product's prices and the components that may influence the prices, such as volume and product quality.
Nur Sufiza Ahmad, Mohd Makmor-Bakry, Ernieda Hatah   +2 more
doaj   +1 more source

A Budding Theory of Willful Patent Infringement: Orange Books, Colored Pills, and Greener Verdicts [PDF]

, 2007
The rules of engagement in the brand-name versus generic-drug war are rapidly changing. Brand-name manufacturers face increasing competition from Canadian manufacturers of generic drugs, online drug companies, and Wal-Mart® Super Centers deciding to cash
Harkins, Christopher A.
core   +1 more source

Molecular cancer prevention: Intercepting disease

Molecular Oncology, EarlyView.
Oncological practice must evolve, from treating established tumours to proactive cancer interception before clinical manifestation. This will require mechanistic insight into tumour initiation, validated biomarkers of early disease development and redesigned clinical trials, enabling cancer interception to become a core pillar of oncology with the ...
Charlotte Grieco, Tej Pandya, Charles Swanton   +2 more
wiley   +1 more source

Undisclosed financial ties between guideline writers and pharmaceutical companies: A cross-sectional study across 10 disease categories [PDF]

, 2019
Objectives To investigate the proportion of potentially relevant undisclosed financial ties between clinical practice guideline writers and pharmaceutical companies.Design Cross-sectional study of a stratified random sample of Australian guidelines and ...
Beller, Elaine, Bero, Lisa, Duggan, Geraint, Goodrick, Stephanie, Jarvis, Huw, Lai, Alexandra, Moynihan, Ray   +6 more
core   +1 more source

Remote Assessment of Ataxia Severity in SCA3 Across Multiple Centers and Time Points

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Spinocerebellar ataxia type 3 (SCA3) is a genetically defined ataxia. The Scale for Assessment and Rating of Ataxia (SARA) is a clinician‐reported outcome that measures ataxia severity at a single time point. In its standard application, SARA fails to capture short‐term fluctuations, limiting its sensitivity in trials.
Marcus Grobe‐Einsler, Vivian Maas, Arian Taheri Amin, Jennifer Faber, Tamara Schaprian, Katharina Hill, Matthis Synofzik, Lisa H. Graf, Heike Jacobi, Manuela Lima, Ana F. Ferreira, Bart P. van de Warrenburg, Ilse H. J. Willemse, Dagmar Timmann, Andreas Thieme, Paola Giunti, Hector Garcia‐Moreno, Magda M. Santana, Jeannette Hübener‐Schmid, Elin H. Davies, Thomas Klockgether   +20 more
wiley   +1 more source